Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/47622
Title: KEYNOTE-042 5-YEAR SURVIVAL UPDATE: PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, PD-L1POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
Authors: CASTRO, Gilberto deKUDABA, IvetaWU, Yi-LongLOPES, GilbertoKOWALSKI, Dariusz M.TURNA, Hande Z.CAGLEVIC, ChristianZHANG, LiKARASZEWSKA, BoguslawaLAKTIONOV, Konstantin K.SRIMUNINNIMIT, VichienBONDARENKO, IgorKUBOTA, KaoruMUKHERJEE, RineeLIN, JianxinSOUZA, FabricioMOK, Tony S. K.CHO, Byoung Chul
Citation: JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, suppl.2, p.A390-A390, 2021
Appears in Collections:

Comunicações em Eventos - FM/MDR
Departamento de Radiologia - FM/MDR

Comunicações em Eventos - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Comunicações em Eventos - LIM/24
LIM/24 - Laboratório de Oncologia Experimental


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.